BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23123793)

  • 1. Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B.
    Ratnam DT; Sievert W; Visvanathan K
    Cell Immunol; 2012 Sep; 279(1):109-15. PubMed ID: 23123793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro immunomodulatory activity of interferon alpha on toll-like receptor 9 signaling pathway in chronic hepatitis B.
    Wang X; Zhao YR; Liu HL; Ma XH; Zhang Y
    J Interferon Cytokine Res; 2015 May; 35(5):385-91. PubMed ID: 25535670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
    Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
    Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signaling.
    Pahl JH; Verhoeven DH; Kwappenberg KM; Vellinga J; Lankester AC; van Tol MJ; Schilham MW
    Mol Immunol; 2012 May; 51(1):91-100. PubMed ID: 22424784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
    Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
    Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers.
    Chen Y; Wei H; Sun R; Tian Z
    Int Immunopharmacol; 2005 Dec; 5(13-14):1839-52. PubMed ID: 16275620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of TLR9 in peripheral blood mononuclear cells of hepatitis B patients].
    Dou JH; Kong M; Wang CH; Jiao SX; Liu Q; Wen ZK
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):61-2. PubMed ID: 20128973
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B.
    Tjwa ET; Zoutendijk R; van Oord GW; Biesta PJ; Verheij J; Janssen HL; Woltman AM; Boonstra A
    Liver Int; 2014 Mar; 34(3):396-404. PubMed ID: 23890390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.
    Tjwa ET; van Oord GW; Hegmans JP; Janssen HL; Woltman AM
    J Hepatol; 2011 Feb; 54(2):209-18. PubMed ID: 21095036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection.
    Martinet J; Dufeu-Duchesne T; Bruder Costa J; Larrat S; Marlu A; Leroy V; Plumas J; Aspord C
    Gastroenterology; 2012 Dec; 143(6):1586-1596.e8. PubMed ID: 22960656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
    Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
    J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-15 activated bovine natural killer cells express CD69 and produce interferon-γ.
    Lund H; Boysen P; Dean GA; Davis WC; Park KT; Storset AK
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):79-89. PubMed ID: 23021353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists.
    Gorski KS; Waller EL; Bjornton-Severson J; Hanten JA; Riter CL; Kieper WC; Gorden KB; Miller JS; Vasilakos JP; Tomai MA; Alkan SS
    Int Immunol; 2006 Jul; 18(7):1115-26. PubMed ID: 16728430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection.
    Zheng Q; Zhu YY; Chen J; Ye YB; Li JY; Liu YR; Hu ML; Zheng YC; Jiang JJ
    Clin Exp Immunol; 2015 Jun; 180(3):499-508. PubMed ID: 25639451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of TLR3-activated myeloid dendritic cell activity leads to improved natural killer cell function in chronic hepatitis B virus infection.
    Tjwa ET; van Oord GW; Biesta PJ; Boonstra A; Janssen HL; Woltman AM
    J Virol; 2012 Apr; 86(8):4102-9. PubMed ID: 22318141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of CD69 levels on TCR Vα7.2
    Yong YK; Tan HY; Saeidi A; Rosmawati M; Atiya N; Ansari AW; Rajarajeswaran J; Vadivelu J; Velu V; Larsson M; Shankar EM
    Innate Immun; 2017 Jul; 23(5):459-467. PubMed ID: 28606013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection.
    Miyagi T; Takehara T; Nishio K; Shimizu S; Kohga K; Li W; Tatsumi T; Hiramatsu N; Kanto T; Hayashi N
    J Hepatol; 2010 Sep; 53(3):424-30. PubMed ID: 20554341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.
    Jurk M; Schulte B; Kritzler A; Noll B; Uhlmann E; Wader T; Schetter C; Krieg AM; Vollmer J
    Immunobiology; 2004; 209(1-2):141-54. PubMed ID: 15481148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.